Search for more clinical trials
Search Trials
Use of Bone Scintigraphy, CT and MRI in Breast Cancer
Conditions
Breast Neoplasms
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
SPECT/CT, MRI, Breast neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
A new imaging modality combining CT and tomographic bone scintigraphy (SPECT/CT) has enabled the combination of functional and anatomical imaging. Its use in cancer patients has not yet been evaluated or validated against a relative gold stand or clinical follow up. The purposes of this study are: 1: to validate the use of conventional planar bone scintigraphy and SPECT combined with low-dose or diagnostic CT and compare this to 3 Tesla MRI and clinical follow up. 2: to compare the specificity of low-dose and diagnostic CT, respectively, combined with bone SPECT. 3: to construct an algorithm for optimal evaluation of disease dissemination in breast cancer patients
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 80 Years
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Histological verified breast cancer

- Age 18-80 years

- Investigation for metastases using imaging modality/modalities planned

- Written consent to participate in trial

Exclusion Criteria:

- Overweight limiting the use of MRI

- Metal parts in body

- Claustrophobia

- Allergy to contrast agents used in trial

- Pregnancy
Location
Aarhus University Hospital
Aarhus, Denmark
Status: Recruiting
Start Date
May 2008
Completion Date
March 2011
Sponsors
University of Aarhus
Source
University of Aarhus
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page
https://clinicaltrials.gov/show/NCT00682253